tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ZBIO Stock Latest News

Zenas BioPharma Reports Q3 2025 Financial Results
Company AnnouncementsZenas BioPharma Reports Q3 2025 Financial Results
22d ago
ZBIO
Zenas BioPharma price target raised to $37 from $34 at Morgan Stanley
PremiumThe Fly
Zenas BioPharma price target raised to $37 from $34 at Morgan Stanley
24d ago
AMGN
ZBIO
Zenas BioPharma’s Promising Autoimmune Platform and Buy Rating Reinforced by Advancements in Obexelimab and Orelabrutinib Trials
PremiumRatings
Zenas BioPharma’s Promising Autoimmune Platform and Buy Rating Reinforced by Advancements in Obexelimab and Orelabrutinib Trials
24d ago
ZBIO
Zenas BioPharma, Inc.: Promising Outlook with Positive Clinical Results and Strong Financial Position Supporting Buy Rating
PremiumRatings
Zenas BioPharma, Inc.: Promising Outlook with Positive Clinical Results and Strong Financial Position Supporting Buy Rating
24d ago
ZBIO
Optimistic Buy Rating for Zenas BioPharma Driven by Promising Clinical Trials and Strong Financial Position
PremiumRatings
Optimistic Buy Rating for Zenas BioPharma Driven by Promising Clinical Trials and Strong Financial Position
24d ago
ZBIO
Zenas BioPharma reports Q3 EPS ($1.22), consensus (85c)
PremiumThe FlyZenas BioPharma reports Q3 EPS ($1.22), consensus (85c)
25d ago
ZBIO
Zenas BioPharma price target raised to $34 from $31 at Morgan Stanley
Premium
The Fly
Zenas BioPharma price target raised to $34 from $31 at Morgan Stanley
1M ago
ZBIO
Promising Phase 2 Results and Strategic Licensing Drive Buy Rating for Zenas BioPharma
Premium
Ratings
Promising Phase 2 Results and Strategic Licensing Drive Buy Rating for Zenas BioPharma
1M ago
ZBIO
Zenas BioPharma price target raised to $46 from $27 at Citi
PremiumThe Fly
Zenas BioPharma price target raised to $46 from $27 at Citi
1M ago
ZBIO
Zenas BioPharma price target raised to $44 from $30 at H.C. Wainwright
PremiumThe Fly
Zenas BioPharma price target raised to $44 from $30 at H.C. Wainwright
1M ago
ZBIO
Midday Fly By: Novartis to buy Avidity, Keurig Dr Pepper beats expectations
PremiumThe Fly
Midday Fly By: Novartis to buy Avidity, Keurig Dr Pepper beats expectations
1M ago
C
NP
Zenas BioPharma Reports Positive Phase 2 Trial Results
PremiumCompany Announcements
Zenas BioPharma Reports Positive Phase 2 Trial Results
1M ago
8K
ZBIO
Zenas BioPharma says obexelimab met primary endpoint in Phase 2 MoonStone trial
PremiumThe FlyZenas BioPharma says obexelimab met primary endpoint in Phase 2 MoonStone trial
1M ago
ZBIO
Zenas BioPharma files to sell 6.31M shares of common stock for holders
Premium
The Fly
Zenas BioPharma files to sell 6.31M shares of common stock for holders
2M ago
ZBIO
Zenas BioPharma: Strategic Licensing and Clinical Advancements Justify Buy Rating
Premium
Ratings
Zenas BioPharma: Strategic Licensing and Clinical Advancements Justify Buy Rating
2M ago
ZBIO
Strategic Expansion and Financial Strength Bolster Zenas BioPharma’s Growth Potential: Buy Rating Reaffirmed
PremiumRatings
Strategic Expansion and Financial Strength Bolster Zenas BioPharma’s Growth Potential: Buy Rating Reaffirmed
2M ago
ZBIO
Zenas BioPharma files automatic mixed securities shelf
PremiumThe Fly
Zenas BioPharma files automatic mixed securities shelf
2M ago
ZBIO
Zenas BioPharma Secures Licensing Deal with InnoCare
PremiumCompany Announcements
Zenas BioPharma Secures Licensing Deal with InnoCare
2M ago
8K
ZBIO
Zenas BioPharma to sell 6.3M shares at $19.00 in private placement
PremiumThe Fly
Zenas BioPharma to sell 6.3M shares at $19.00 in private placement
2M ago
ZBIO
Zenas BioPharma, InnoCare Pharma announce orelabrutinib license agreement
PremiumThe FlyZenas BioPharma, InnoCare Pharma announce orelabrutinib license agreement
2M ago
ZBIO
Strategic Funding Boost: Zenas BioPharma’s Partnership with Royalty Pharma Enhances Obexelimab’s Commercial Potential
Premium
Ratings
Strategic Funding Boost: Zenas BioPharma’s Partnership with Royalty Pharma Enhances Obexelimab’s Commercial Potential
3M ago
ZBIO
Zenas BioPharma Secures $300M Funding for Obexelimab
Premium
Company Announcements
Zenas BioPharma Secures $300M Funding for Obexelimab
3M ago
8K
ZBIO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >